The transmembrane 6 superfamily member 2 (TM6SF2) gene, functioning in lipid metabolism, is also related to an increased risk of MASLD progression [16]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.